Literature DB >> 8600049

Rhabdomyoblastic differentiation in a leiomyosarcoma of the retroperitoneum.

F Roncaroli1, V Eusebi.   

Abstract

A case of leiomyosarcoma of the retroperitoneum with rhabdomyoblastic areas which developed in a 59-year-old woman is reported. The tumor was composed mostly of spindle cells immunoreactive with desmin and smooth muscle actin antisera. In the lesion there were no fewer than five patches constituted by large pleomorphic elements which reacted with antidesmin, sarcomeric actin and myoglobin antisera. These dual features were interpreted as the result of a divergent differentiation of neoplastic cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8600049     DOI: 10.1016/s0046-8177(96)90075-1

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  5 in total

1.  Leiomyosarcoma of the female breast.

Authors:  E Székely; L Madaras; J Kulka; B Járay; L Nagy
Journal:  Pathol Oncol Res       Date:  2001       Impact factor: 3.201

2.  Human pancreatic leiomyosarcoma (PZX-7) growing as a serially transplantable xenograft in immunosuppressed mice.

Authors:  A Zalatnai; J Bocsi; T Csákány; T Fekete; J Lásztity
Journal:  Int J Pancreatol       Date:  1999-08

3.  Recurrent high-grade leiomyosarcoma with heterologous osteosarcomatous differentiation.

Authors:  Florian Grabellus; Sien-Yi Sheu; Boris Schmidt; Michael Flasshove; Cornelius Kuhnen; Steffen Ruchholtz; Georg Taeger; Kurt Werner Schmid
Journal:  Virchows Arch       Date:  2005-10-14       Impact factor: 4.064

4.  Leiomyosarcomas of great vessels.

Authors:  E Székely; J Kulka; I Miklós; P Kaliszky
Journal:  Pathol Oncol Res       Date:  2000       Impact factor: 3.201

5.  Leiomyosarcoma with partial rhabdomyoblastic differentiation: first case report of primary cardiac origin.

Authors:  Yoichiro Okubo; Kazutoshi Shibuya; Atsushi Namiki; Kazuhisa Takamura; Noriaki Kameda; Tetsuo Nemoto; Aki Mitsuda; Megumi Wakayama; Minoru Shinozaki; Nobuyuki Hiruta; Kanako Kitahara; Takao Ishiwatari; Junichi Yamazaki
Journal:  BMC Cancer       Date:  2011-02-17       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.